メタボローム研究チーム

欧文誌

List

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
1995-2002
和文誌

 

2023

  1. Honda A, Nozumi M, Ito Y, Natsume R, Kawasaki A, Nakatsu F, Abe M, Uchino H, Matsushita N, Ikeda K, Arita M, Sakimura K, *Igarashi M. Very-long-chain fatty acids (VLCFAs) are Crucial to Neuronal Polarity by Providing Sphingolipids to Lipid-Rafts. Cell Rep in press
  2. Kuroha S, Katada Y, Isobe Y, Uchino H, Shishikura K, Nirasawa T, Tsubota K, Negishi K, *Kurihara T, *Arita M. Long chain acyl-CoA synthetase 6 facilitates the local distribution of di-docosahexaenoic acid- and ultra-long-chain-PUFA-containing phospholipids in the retina to support normal visual function in mice. FASEB J 37, e23151 (2023)
  3. Takeuchi T, *Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon A, Yazaki J, Ikeda K, Nemoto S, Mochizuki Y, Kitami T, Yugi K, Mizuno Y, Yamamichi N, Yamazaki T, Takamoto I, Kubota N, Kadowaki T, Arner E, Carninci P, Ohara O, Arita M, Hattori M, Koyasu, S, *Ohno H. Gut microbiota carbohydrate metabolism contributes to insulin resistance. Nature 621, 389-395 (2023)
  4. *Mi-ichi F, Tsugawa H, Yoshida H, *Arita M. Unique features of Entamoeba glycerophospholipid metabolism; has the Entamoeba lipid metabolism network evolved through gene loss and gain to enable parasitic life cycle adaptation? mSphere in press
  5. *Miyoshi T, Naoe S, Wakabayashi H, Yano T, Mori T, Kanda S, Arita M, Ito H. Enhanced production of EPA-derived anti-inflammatory metabolites after oral administration of a novel self-emulsifying highly purified EPA ethyl ester formulation (MND-2119). J Atheroscler Thromb in press
  6. Sugihara R, Taneike M, Murakawa T, Tamai T, Ueda H, Kitazume-Taneike R, Oka T, Akazawa Y, Nishida H, Mine K, Hioki A, Omi J, Omiya S, Aoki J, Ikeda K, Nishida K, Arita M, Yamaguchi O, *Otsu K. Lysophosphatidylserine induces necrosis in pressure overloaded male mouse hearts via G protein coupled receptor 34. Nat Commun 14, 4494 (2023)
  7. Shiratori H, Oguchi H, Isobe Y, Han KH, Sen A, Yakebe K, Takahashi D, Fukushima M, *Arita M, *Hase K. Gut microbiota-derived lipid metabolites facilitate regulatory T cell differentiation. Sci Rep 13, 8903 (2023)
  8. Iino Y, Naganuma T, *Arita M. Dysregulated ceramide metabolism in mouse progressive dermatitis resulting from constitutive activation of Jak1. J Lipid Res 64, 100329 (2023)
  9. Ikizawa T, Ikeda K, Arita M, Kitajima S, Soga T, *Ichijo H, *Naguro I. Mitochondria directly sense osmotic stress to trigger rapid metabolic remodeling via regulation of pyruvate dehydrogenase (PDH) phosphorylation. J Biol Chem 299, 102837 (2023)
  10. Aoki H, Isobe Y, Yoshida M, Kang JX, Maekawa M, *Arita M. Enzymatically-epoxidized docosahexaenoic acid, 19,20-EpDPE, suppresses hepatic crown-like structure formation and nonalcoholic steatohepatitis fibrosis through GPR120. Biochim Biophys Acta Mol Cell Biol Lipids 1868, 159275 (2023)
  11. *Lopez-Vicario C, Sebastian D, Casulleras M, Duran-Guell M, Flores-Costa R, Aguilar F, Lozano JJ, Zhang IW, Titos E, Kang JX, Zorzano A, Arita M, *Claria J. Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease.  Hepatology  77, 1303-1318 (2023)

>> List

2022

  1. Ariyasu Y, Sato Y, Isobe Y, Taniguchi K, *Yanagita M, *Arita M. Sterol O-acyltransferase inhibition ameliorates high-fat diet-induced renal fibrosis and tertiary lymphoid tissue maturation after ischemic reperfusion injury. Int J Mol Sci 23, 15465 (2022)
  2. Uchino H, *Tsugawa H, Takahashi H, *Arita M. Computational mass spectrometry accelerates C=C position-resolved untargeted lipidomics using oxygen attachment dissociation. Commun Chem 5, 162 (2022)
  3. Yoshida M, Ishihara T, Isobe Y, *Arita M. Genetic deletion of Cyp4f18 disrupts the omega-3 epoxidation pathway and results in psoriasis-like dermatitis. FASEB J 36, e22648 (2022)
  4. *Tsuji K, Shimada W, Kishino S, Ogawa J, Arita M. Comprehensive analysis of 10-hydroxy-cis-12-octadecenoic acid (HYA) and related fatty acid metabolites produced by gut microbiota using LC-MS/MS-based lipidomics. Medical Mass Spectrometry 6, 112-125 (2022)
  5. McDonald JG, Ejsing CS, Kopczynski D, Holcapek M, Aoki J, Arita M, Arita M, Baker ES, Bertrand-Michel J, Bowden JA, Brugger B, Ellis SR, Fedorova M, Griffiths WJ, Han X, Hartler J, Hoffmann N, Koelmel JP, Kofeler HC, Mitchell TW, O’Donnell VB, Saigusa D, Schwudke D, Shevchenko A, Ulmer CZ, Wenk MR, Witting M, Wolrab D, Xia Y, *Ahrends R, *Liebisch G, *Ekroos K. Introducing the lipidomics minimal reporting checklist.  Nat Metab  4, 1086-1088 (2022)
  6. *Mi-ichi F, Tsugawa H, Arita M, Yoshida H. Pleiotropic roles of cholesteryl sulfate during Entamoeba encystation; involvement in cell rounding and development of membrane impermeability.  mSphere   7, e0029922 (2022)
  7. Morimoto K, Fukuda K, Ito Y, Tahara U, Sasaki T, Shiohama A, Kawasaki H, Kawakami E, Naganuma T, Arita M, Sasaki H, Koseki H, Matsui T, *Amagai M. Microbiota-independent spontaneous dermatitis associated with increased sebaceous lipid production in Tmem79-deficient mice.  J Invest Dermatol  142, 2864-2872 (2022)
  8. Mori K, Kuroha S, Hou J, Jeong H, Ogawa M, Ikeda S, Kang JX, Negishi K, Torii H, *Arita M, *Kurihara T, Tsubota K. Lipidomic analysis revealed n-3 polyunsaturated fatty acids suppressed choroidal thinning and myopia progression in mice.  FASEB J 36, e22312 (2022)  
  9. Naganuma T, Funinami N, *Arita M. Polyunsaturated fatty acid-derived lipid mediators that regulate epithelial homeostasis.  Biol Pharm Bull  45, 998-1007 (2022)
  10. Nagatake T, Kishino S, Urano E, Murakami H, Kitamura N, Konishi K, Ohno H, Tiwari P, Morimoto S, Node E, Adachi J, Abe Y, Isoyama J, Sawane K, Honda T, Inoue A, Uwamizu A, Matsuzaka T, Miyamoto Y, Hirata S, Saika A, Shibata Y, Hosomi K, Matsunaga A, Shimano H, Arita M, Aoki J, Oka M, Matsutani A, Tomonaga T, Kabashima K, Miyachi M, Yasutomi Y, Ogawa J, *Kunisawa J. Intestinal microbiome-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaques. Mucosal Immunol 15, 289-300 (2022)
  11. Miki Y, Taketomi Y, Kidoguchi Y, Yamamoto K, Muramatsu K, Nishito Y, Park J, Hosomi K, Mizuguchi K, Kunisawa J, Soga T, Boilard E, Gowda SG, Ikeda K, Arita M, *Murakami M. Group IIA secreted phospholipase A2 controls skin carcinogenesis and psoriasis by shaping the gut microbiota. JCI Insight 7, e152611 (2022)
  12. Dore E, Joly-Beauparlant C, Morozumi S, Mathieu A, Levesque T, Allaeys I, Duchez A, Cloutier N, Leclercq M, Bodein A, Payre C, Martin C, Petit-Paitel A, Gelb M, Rangachari M, Murakami M, Davidovic L, Flamand N, Arita M, Lambeau G, Droit A, *Boilard E. The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation. JCI Insight 7, e152638 (2022)
  13. Morozumi S, Ueda M, Okahashi N, *Arita M. Structures and functions of the gut microbial lipidome. Biochim Biophys Acta Mol Cell Biol Lipids 1867, 159110 (2022)

>> List

2021

  1. Aoyagi R, Yamamoto T, Furukawa Y, *Arita M. Characterization of the structural diversity and structure-specific behavior of oxidized phospholipids by LC-MS/MS. Chem Pharm Bull 69, 953-961 (2021)
  2. Tokuhiro T, Ishizawa A, Sato H, Takita S, Yoshikawa A, Anzai R, Sato S, Aoyagi R, Arita M, Aratani Y, Shimizu S, Tanaka M, *Yotsumoto S. Oxidized phospholipids and neutrophil elastase coordinately play critical roles in NET formation. Front Cell Dev Biol 9, 718586 (2021)
  3. Kuwashima Y, *Yanagawa M, Abe M, Hiroshima M, Ueda M, Arita M, *Sako Y. Comparative analysis of single-molecule dynamics of TRPV1 and TRPV4 channels in living cells. Int J Mol Biol 22, 8473 (2021)
  4. Kong WS, Tsuyama N, Inoue H, Guo Y, Mokuda S, Nobukiyo A, Nakatani N, Yamaide F, Nakano T, Kohno Y, Ikeda K, Nakanishi Y, Ohno H, Arita M, Shimojo N, *Kanno M. Long-chain saturated fatty acids in breast milk are associated with the pathogenesis of atopic dermatitis via induction of inflammatory ILC3s. Sci Rep 11, 13109 (2021)
  5. Kikuchi K, Tatebe T, Sudo Y, Yokoyama M, Kidana K, Chiu Y, Takatori S, Arita M, Hori Y, *Tomita T. GPR120 signaling controls amyloid-b degrading activity of matrix metalloproteinases. J Neurosci 41, 6173-6185 (2021)
  6. Miyata J, Yokokura Y, Moro K, Arai H, Fukunaga K, *Arita M. 12/15-Lipoxygenase regulates IL-33-induced eosinophilic airway inflammation in mice. Front Immunol 12, 687192 (2021)
  7. Osada H, Toda E, Homma K, Guzman NA, Nagai N, Ogawa M, Negishi K, Arita M, Tsubota K, *Ozawa Y. ADIPOR1 deficiency-induced suppression of retinal ELOVL2 and docosahexaenoic acid levels during photoreceptor degeneration and visual loss. Cell Death Dis 12, 458 (2021)
  8. Ito Y, Sasaki T, Li Y, Tanoue T, Sugiura Y, Skelly AN, Suda W, Kawashima Y, Okahashi N, Watanabe E, Horikawa H, Shiohama A, Kurokawa R, Kawakami E, Iseki H, Kawasaki H, Iwakura Y, Shiota A, Yu L, Hisatsune J, Koseki H, Sugai M, Arita M, Ohara O, Matsui T, Suematsu M, Hattori M, Atarashi K, Amagai M, *Honda K. Staphylococcus cohnii is a potentially biotherapeutic skin commensal alleviating skin inflammation. Cell Rep 35, 109052 (2021)
  9. Okahashi N, Ueda M, Yasuda S, Tsugawa H, *Arita M. Global profiling of gut microbiota-associated lipid metabolites in antibiotic-treated mice by LC-MS/MS-based analyses. STAR Protoc. 2, 100492 (2021)
  10. *Okahashi N, Ueda M, Matsuda F, *Arita M.Analysis of lipid A in gram-negative intestinal bacteria using liquid chromatography-quadrupole time-of-flight mass spectrometry. Metabolites 11, 197 (2021)
  11. Nishimura T, Oyama T, Hu HT, Fujioka T, Hanawa-Suetsugu K, Ikeda K, Yamada S, Kawana H, Saigusa D, Ikeda H, Kurata R, Oono-Yakura K, Kitamata M, Kida K, Hikita T, Mizutani K, Yasuhara K, Mimori-Kiyosue Y, Oneyama C, Kurimoto K, Hosokawa Y, Aoki J, Takai Y, Arita M, *Suetsugu S.Filopodium-derived vesicles produced by MIM enhance the migration of recipient cells. Dev Cell 56, 842-859 (2021)
  12. Saika A, Nagatake T, Hirata S, Sawane K, Adachi J, Abe Y, Isoyama J, Morimoto S, Node E, Tiwari P, Hosomi K, Matsunaga A, Honda T, Tomonaga T, Arita M, Kabashima K, *Kunisawa J.ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α. FASEB J 35, e21354 (2021)
  13. *Mi-ichi F, Ikeda K, Tsugawa H, Deoler S, Yoshida H, *Arita M.Stage-specific de novo synthesis of very long chain dihydroceramides confers dormancy in Entamoeba parasites. mSphere 6, e00174-21 (2021)
  14. Takahashi N, Kikuchi H, Usui A, Furusho T, Fujimaru T, Fujiki T, Yanagi T, Matsuura Y, Asano K, Yamamoto K, Ando F, Susa K, Mandai S, Mori T, Rai T, Uchida S, *Arita M, *Sohara E.Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney. Clin Exp Nephrol 25, 445-455 (2021)
  15. Hirata T, Yamamoto K, Ikeda K, *Arita M. Functional lipidomics of vascular endothelial cells in response to laminar shear stress. FASEB J 35, e21301 (2021)
  16. Nagata M, Toyonaga K, Ishikawa E, Haji S, Okahashi N, Takahashi M, Izumi Y, Imamura A, Takato K, Ishida H, Nagai S, Illarinov P, Stocker BL, Timmer M, Smith D, Williams SJ, Bamba T, Miyamoto T, Arita M, Appelmelk BJ, *Yamasaki S.Helicobacter pylori metabolites exacerbate gastritis through C-type lectin receptors. J Exp Med 218, e20200815 (2021)
  17. Johmura Y, Yamanaka T, Omori S, Wang T, Sugiura Y, Matsumoto M, Suzuki N, Kumamoto S, Yamaguchi K, Hatakeyama S, Takami T, Yamaguchi R, Shimizu E, Ikeda K, Okahashi N, Mikawa R, Suematsu M, Arita M, Sugimoto M, Nakayama K, Furukawa Y, Imoto S, *Nakanishi M.Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science 371, 265-270 (2021)
  18. Nakashima Y, *Sakai Y, Mizuno Y, Furuno K, Hirono K, Takatsuki S, Suzuki H, Onouchi Y, Kobayashi T, Tanabe K, Hamase K, Miyamoto T, Aoyagi R, Arita M, Yamamura K, Tanaka T, Nishio H, Takada H, Ohga S, *Hara T. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease. Cardiovasc Res 117, 96-108 (2021)
  19. Ogawa K, Asano K, Yotsumoto S, Yamane T, Arita M, Hayashi Y, Harada H, Makino-Okamura C, Fukuyama H, Kondo K, Yamasoba T, *Tanaka M. Frontline Science: Conversion of neutrophils into atypical Ly6G+SiglecF+ immune cells with neurosupportive potential in olfactory neuroepithelium. J Leukoc Biol 109, 481-496 (2021)

>> List

2020

  1. *Sakayori N, Katakura M, Hamazaki K, Higuchi O, Fujii K, Fukabori R, Iguchi Y, Setogawa S, Takao K, Miyazawa T, Arita M, Kobayashi K. Maternal dietary imbalance between omega-6 and omega-3 fatty acids triggers the offspring’s overeating in mice. Commun Biol 3, 473 (2020)
  2. Ogawa M, Ishihara T, Isobe Y, Kato T, Kuba K, Imai Y, Uchino Y, Tsubota K, *Arita M. Eosinophils promote corneal wound healing via the 12/15-lipoxygenase pathway. FASEB J 34, 12492-12501 (2020)
  3. Sanjo H, Yao T, Katagiri K, Sato T, Matsumura T, Komeya M, Yamanaka H, Yao M, Matsuhisa A, Asayama Y, Ikeda K, Kano K, Aoki J, Arita M, *Ogawa T. Antioxidant vitamins and lysophospholipids are critical in inducing mouse spermatogenesis under organ culture condition. FASEB J 34, 9480-9497 (2020)
  4. *Tsugawa H, Ikeda K, Takahashi M, Satoh A, Mori Y, Uchino H, Okahashi N, Yamada Y, Tada I, Bonini P, Higashi Y, Okazaki Y, Zhou Z, Zhu Z, Koelmel J, Cajka T, Fiehn O, Saito K, Arita M, *Arita M. A lipidome atlas in MS-DIAL 4. Nat Biotechnol 38, 1159-1163 (2020)
  5. Morita M, Saito S, Shinohara R, Aoyagi R, Arita M, *Kobayashi Y. Synthesis of phosphatidylcholines possessing functionalized acids at sn-2, and 13C-14N and 13C-31P couplings in their 13C NMR spectra. Synlett 31, 718-722 (2020)
  6. *Sasaki H, Kaneda Y, Rogi T, Shibata H, Aoyagi R, Yamane T, Ikeda K, Arita M. Aging alters lipid mediator biosynthesis from polyunsaturated fatty acids in the brain of senescence-accelerated mice with age-related cognitive dysfunction. Medical Mass Spectrometry 4, 65-75 (2020)
  7. *Kimura I, Miyamoto J, Ohue-Kitano R, Watanabe K, Yamada T, Onuki M, Aoki R, Isobe Y, Kashihara D, Inoue D, Inaba A, Takamura Y, Taira S, Kumaki S, Watanabe M, Ito M, Nakagawa F, Irie J, Kakuta H, Shinohara M, Iwatsuki K, Tsujimoto G, Ohno H, Arita M, Itoh H, *Hase K. Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science 367, eaaw8429 (2020)
  8. Hirata SI, Nagatake T, Sawane K, Hosomi K, Honda T, Ono S, Ikeda K, Aoyagi R, Adachi J, Abe Y, Isoyama J, Suzuki H, Tomonaga T, Kiyono H, Kabashima K, Arita M, *Kunisawa J. Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL-expressing plasmacytoid dendritic cells in mice. Allergy 75, 1935-1951 (2020)
  9. Utsunomiya A, Chino T, Utsunomiya N, Luong VH, Tokuriki A, Naganuma T, Arita M, Higashi K, Saito K, Suzuki N, Ohara A, Sugai M, Sugawara K, Tsuruta D, Oyama N, *Hasegawa M. Homeostatic function of dermokine in the skin barrier and inflammation. J Invest Dermatol 140, 838-849 (2020)
  10. Miyata J, *Fukunaga K, Kawashima Y, Ohara O, Arita M. Cysteinyl leukotriene metabolism of human eosinophils in allergic disease. Allergol Int 69, 28-34 (2020)
  11. *Miyata J, Fukunaga K, Kawashima Y, Ohara O, Kawana A, Asano K, Arita M. . Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergy diseases. Prostaglandins Other Lipid Mediat 150, 106477 (2020)
  12. Kokaji T, Hatano A, Ito Y, Yugi K, Eto M, Morita K, Ohno S, Fujii M, Hironaka K, Egami R, Terakawa A, Tsuchiya T, Ozaki H, Inoue H, Uda S, Kubota H, Suzuki Y, Ikeda K, Arita M, Matsumoto M, Nakayama K, Hirayama A, Soga T, *Kuroda S. Transomics analysis reveals allosteric and gene regulation axes for altered hepatic glucose-responsive metabolism in obesity. Sci Signal 13, eaaz1236 (2020)
  13. Yasuda S, Okahashi N, Tsugawa H, Ogata Y, Ikeda K, Suda W, Arai H, Hattori M, *Arita M. Elucidation of gut microbiota-associated lipids using LC-MS/MS and 16S rRNA sequence analyses. iScience 23, 101841 (2020)

>> List

2019

  1. Sawane K, Nagatake T, Hosomi K, Hirata S, Adachi J, Abe Y, Isoyama J, Suzuki H, Matsunaga A, Fukumitsu S, Aida K, Tomonaga T, Arita M, *Kunisawa J. Dietary omega-3 fatty acid ameliorates allergic rhinitis via eosinophilic production of the anti-allergic lipid mediator 15-hydroxyeicosapentaenoic acid in mice. Nutrients 11, 2868 (2019)
  2. Naoe S, *Tsugawa H, Takahashi M, Ikeda K, *Arita M. Characterization of lipid profiles after dietary intake of polyunsaturated fatty acids using integrated untargeted and targeted lipidomics. Metabolites 9, 241 (2019)
  3. Shishikura K, Kuroha S, Matsueda S, Iseki H, Matsui T, Inoue A, *Arita M. Acyl-CoA synthetase 6 regulates long chain polyunsaturated fatty acid composition of membrane phospholipids in spermatids and supports normal spermatogenic processes in mice. FASEB J 33, 14194-14203 (2019)
  4. Miyamoto J, Igarashi M, Watanabe K, Karaki SI, Mukouyama H, Kishino S, Li X, Ichimura A, Irie J, Sugimoto Y, Mizutani T, Sugawara T, Miki T, Ogawa J, Drucker DJ, Arita M, Itoh H, *Kimura I. Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids. Nat Commun 10, 4007 (2019)
  5. Sato T, Horikawa M, Takei S, Yamazaki F, Ito TK, Kondo T, Sakurai T, Kahyo T, Ikegami K, Sato S, Sato R, Jinno Y, Kawano H, Naoe S, Arita M, Kashiwagi Y, *Setou M. Preferential incorporation of administered eicosapentaenoic acid into thin-cap atherosclerotic plaques. Arterioscler Thromb Vasc Biol 39, 1802-1816 (2019)
  6. Liebisch G, Ahrends R, Arita M, Arita M, Bowden JA, Ejsing CS, Griffiths WJ, Holcapek M, Kofeler H, Mitchell TW, Wenk MR, Ekroos K. (Lipidomics Standards Initiative Consortium). 2019. Lipidomics needs more standardization. Nat Metab 1, 745-747 (2019)
  7. Watanabe Y, *Nagai Y, Honda H, Okamoto N, Yanagibashi T, Ogasawara M, Yamamoto S, Imamura R, Takasaki I, Hara H, Sasahara M, Arita M, Hida S, Taniguchi S, Suda T, *Takatsu K. Bi-directional crosstalk between neutrophils and adipocytes promotes adipose tissue inflammation. FASEB J 33, 11821-11835
  8. *Tsugawa H, Satoh A, Uchino H, Cajka T, Arita M, *Arita M. Mass spectrometry data repository enhances novel metabolite discoveries with advances in computational metabolomics. Metabolites 9, E119 (2019)
  9. Miyata J, Fukunaga K, Kawashima Y, Watanabe T, Saitoh A, Hirosaki T, Araki Y, Kikawada T, Betsuyaku T, Ohara O, *Arita M. Dysregulated fatty acid metabolism in nasal polyp-derived eosinophils from patients with chronic rhinosinusitis. Allergy 74, 1113-1124 (2019)
  10. *Imanishi T, Unno M, Kobayashi W, Yoneda N, Matsuda S, Ikeda K, Hoshi T, Hirao A, Miyake K, Barber GN, Arita M, Ishii KJ, Akira S, *Saito T. Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function. Life Sci Alliance 2, e201800282 (2019)
  11. Kawashima Y, Miyata J, Watanabe T, Shioya J, Arita M, *Ohara O. Proteogenomic analyses of cellular lysates using a phenol-guanidium thiocyanate reagent. J Proteome Res 18, 301-308 (2019)
  12. Yamamoto T, *Miyata J, Arita M, Fukunaga K, Kawana A. Current state and future prospect of therapeutic strategy targeting cysteinyl leukotriene metabolism in asthma. Respir Invest 57, 534-543 (2019)
  13. Ishihara T, Yoshida M, *Arita M. Omega-3 fatty acid–derived mediators that control inflammation and tissue homeostasis. Int Immunol 31, 559-567 (2019)

>> List

2018

  1. Mizukami T, Ikeda K, Shimanaka Y, Korogi K, Zhou C, Takase H, Tsuiji H, Kono N, Kohno T, Arai H, Arita M, *Hattori M. Reelin deficiency leads to aberrant lipid composition in mouse brain. Biochem Biophys Res Commun 505, 81-86 (2018)
  2. Li J, Chen CY, Arita M, Kim K, Li X, Zhang H, *Kang JX. An omega-3 polyunsaturated fatty acid derivative, 18-HEPE, protects against CXCR4-associated melanoma metastasis. Carcinogenesis 39, 1380-1388(2018)
  3. Burla B, Arita M, Arita M, Bendt AK, Cazenave-Gassiot A, Dennis EA, Ekroos K, Han X, Ikeda K, Liebisch G, Lin MK, Loh TP, Meikle PJ, Oresic M, Quehenberger O, Shevchenko A, Torta F, Wakelam MJO, Wheelock CE, *Wenk MR. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines. J Lipid Res 59, 2001-2017 (2018)
  4. Ueharaguchi Y, *Honda T, Kusuba N, Hanakawa S, Adachi A, Sawada Y, Otsuka A, Kitoh A, Dainichi T, Egawa G, Nakashima C, Nakajima S, Murata T, Ono S, Arita M, Narumiya S, Miyachi Y, Kabashima K. Thromboxane A2 facilitates IL-17A production from Vg4+ gdT cells and promotes psoriatic dermatitis in mice. J Allergy Clin Immunol 142, 680-683 (2018)
  5. Nagatake T, Shiogama Y, Inoue A, Kikuta J, Honda T, Tiwari P, Kishi T, Yanagisawa A, Isobe Y, Matsumoto N, Shimojou M, Morimoto S, Suzuki H, Hirata S, Steneberg P, Edlund H, Aoki J, Arita M, Kiyono H, Yasutomi Y, Ishii M, Kabashima K, *Kunisawa J. The 17,18-epoxyeicosatetraenoic acid-G protein-coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques. J Allergy Clin Immunol 142, 470-484 (2018)
  6. Yamada M, Takahashi N, Matsuda Y, Sato K, Yokoji M, Sulijaya B, Maekawa T, Ushiki T, Mikami Y, Hayatsu M, Mizutani Y, Kishino S, Ogawa J, Arita M, Tabeta K, Maeda T, *Yamazaki K. A bacterial metabolite ameliorates periodontal pathogen-induced gingival epithelial barrier disruption via GPR40 signaling. Sci Rep 8, 9008 (2018)
  7. Gowda SG, Ikeda K, *Arita M. Facile determination of sphingolipids under alkali condition using metal-free column by LC-MS/MS. Anal Bioanal Chem 410, 4793-4803 (2018)
  8. *Isobe Y, Itagaki M, Ito Y, Naoe S, Kojima K, Ikeguchi M, *Arita M.Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid. Sci Rep 8, 7954 (2018)
  9. Hata M, *Ikeda H, Iwai S, Iida Y, Gotoh N, Asaka I, Ikeda K, Isobe Y, Hori A, Nakagawa S, Yamato S, Arita M, Yoshimura N, Tsujikawa A.Reduction of lipid accumulation rescues Bietti’s crystalline dystrophy phenotypes. Proc Natl Acad Sci USA 115, 3936-3941 (2018)
  10. *Isobe Y, Kawashima Y, Ishihara T, Watanabe K, Ohara O, *Arita M.Identification of protein targets of 12/15-lipoxygenase-derived lipid electrophiles in mouse peritoneal macrophages using omega-alkynyl fatty acid. ACS Chem Biol 13, 887-893 (2018)
  11. Nosaka T, *Baba T, Tanabe Y, Sasaki S, Nishimura T, Imamura Y, Yurino H, Hashimoto S, Arita M, Nakamoto Y, Mukaida Y.Alveolar macrophages drive hepatocellular carcinoma lung metastasis by generating leukotriene B4. J Immunol 200, 1839-1852 (2018)
  12. Mochimaru T, *Fukunaga K, Miyata J, Matsusaka M, Masaki K, Kabata H, Ueda S, Suzuki Y, Goto T, Urabe D, Inoue M, Isobe Y, Arita M, Betsuyaku T. 12-OH-17,18-epoxyeicosatetraenoic acid alleviates eosinophilic airway inflammation in murine lungs. Allergy 73, 369-378 (2018)
  13. Codagnone M, Cianci E, Lamolinara A, Cecilia Mari V, Nespoli A, Arita M, Bragonzi A, Iezzi M, Romano M, *Recchiuti A. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol 11, 35-49 (2018)
  14. Nishimura K, Sakaguchi T, Nanba Y, Suganuma Y, Morita M, Hong S, Lu Y, Jun B, Bazan NG, Arita M, *Kobayashi Y. Stereoselective total synthesis of macrophage-produced prohealing 14,21-dihydroxydocosahexaenoic acids. J Org Chem 83, 154-166 (2018)

>> List

2017

  1. Tsugawa H, Ikeda K, *Arita M. The importance of bioinformatics for connecting data-driven lipidomics and biological insights. Biochim Biophys Acta 1862, 762-765 (2017)
  2. *Ikutani M, Tsuneyama K, Kawaguchi K, Fukuoka J, Kudo F, Nakae S, Arita M, Nagai Y, Takaki S, *Takatsu K. Prolonged activation of IL-5 producing ILC2 causes pulmonary arterial hypertrophy. JCI Insight 2, e90721 (2017)
  3. Tsugawa H, Ikeda K, Tanaka W, Senoo Y, *Arita M, *Arita M. Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library. J Cheminform 9, 19 (2017)
  4. Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, Ozawa T, Nakamura M, Kumagai M, Watashi K, Taketo M, Aoki T, Narumiya S, Oshima M, Arita M, Hara E, *Ohtani N. Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity. Cancer Discov 7, 522-538 (2017)
  5. Hirabayashi T, Anjo T, Kaneko A, Senoo Y, Shibata A, Takama H, Yokoyama K, Nishito Y, Ono T, Taya C, Muramatsu K, Fukami K, Muñoz-Garcia A, Brash AR,Ikeda K, Arita M, Akiyama M, *Murakami M. PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis. Nature Commun 8, 14609 (2017)
  6. Aoyagi R, Ikeda K, Isobe Y, *Arita M. Comprehensive analyses of oxidized phospholipids using a measured MS/MS spectra library. J Lipid Res 58, 2229-2237 (2017)
  7. Shimanaka Y, Kono N, Taketomi Y, Arita M, Okayama Y, Tanaka Y, Nishito Y, Mochizuki T, Kusuhara H, Adibekian A, Cravatt BF, *Murakami M, *Arai H. Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation. Nat Med 23, 1287-1297 (2017)
  8. Yotsumoto S, Muroi Y, Chiba T, Ohmura R, Yoneyama M, Magarisawa M, Dodo K, Terayama N, Sodeoka M, Aoyagi R, Arita M, Arakawa S, Shimizu S, *Tanaka M. Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation. Sci Rep 7, 16026 (2017)
  9. *Takahashi H, Shida D, Tagawa K, Iwamoto R, Arita M, Arai H, Suzuki T. Therapeutic effects of flurbiprofen axetil on mesenteric traction syndrome: randomized clinical trial. BMC Surg 17, 90 (2017)
  10. 5. Aikawa S, Kano K, Inoue A, Wang J, Saigusa D, Nagamatsu T, Hirota Y, Fujii T, Tsuchiya S, Taketomi Y, Sugimoto Y, Murakami M, Arita M, Kurano M, Ikeda H, Yatomi Y, Chun J, *Aoki J. Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways. EMBO J 36, 2146-2160 (2017)

>> List

2016

  1. Sato Y, Mii A, Hamazaki Y, Fujita H, Nakata H, Masuda K, Nishiyama S, Shibuya S, Haga H, Ogawa O, Shimizu A, Narumiya S, Kaisho T, Arita M, Yanagisawa M, Miyasaka M, Sharma K, Minato N, Kawamoto H, *Yanagita M. Heterogenous fibroblasts underlie age-dependent tertially lymphoid tissues in the kidney. JCI Insight 1, e87680 (2016)
  2. *Arita M. Eosinophil polyunsaturated fatty acid metabolism and its potential control of inflammation and allergy. Allergol Int 65, S2-S5 (2016)
  3. Endo J, *Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardiol 67, 22-27 (2016)
  4. Sakayori N, Kikkawa T, Tokuda H, Kiryu E, Yoshizaki K, Kawashima H, Yamada T, Arai H, Kang JX, Katagiri H, Shibata H, Innis SM, Arita M, *Osumi N. Maternal dietary balance between omega-6 and omega-3 polyunsaturated fatty acids impairs neocortical development via epoxy metabolites. Stem Cells 34, 470-482 (2016)

>> List

2015

  1. Katakura M, *Hashimoto M, Inoue T, Mamun AA, Tanabe Y, Arita M, Shido O. Chronic arachidonic acid administration decreases docosahexaenoic acid and eicosapentaenoic acid-derived metabolites in kidneys of aged rats. PLoS One 10, e0140884 (2015)
  2. Sawada Y, *Honda T, Hanakawa S, Nakamizo S, Murata T, Ueharaguchi-Tanada Y, Ono S, Amano W, Nakajima S, Egawa G, Tanizaki H, Otsuka A, Kitoh A, Dainichi T, Ogawa N, Kobayashi Y, Yokomizo T, Arita M, Nakamura M, Miyachi Y, *Kabashima K. Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. J Exp Med 212, 1921-1930 (2015)
  3. *Hirahashi J, Hanafusa N, Wada T, Arita M, Hishikawa K, Hayashi M, Nangaku M. Aspirin and eicosapentaenoic acid may arrest progressive IgA nephropathy: a potential alternative to immunosuppression. Intern Med 54, 2377-2382 (2015)
  4. Nakato M, Matsuo M, Kono N, Arita M, Arai H, Ogawa J, Kioka N, *Ueda K. Neurite outgrowth stimulation by n3 and n6 polyunsaturated fatty acids of phospholipids in apolipoprotein E containing lipoproteins secreted from glial cells. J Lipid Res 56, 1880-1890 (2015)
  5. Goto T, Urabe D, Masuda K, Isobe Y, Arita M, *Inoue M. Total synthesis of four stereoisomers of (4Z,7Z,10Z,12E,16Z,18E)-14,20-dihydroxy-4,7,10,12,16,18-docosahexaenoic acid and their anti-inflammatory activities. J Org Chem 80, 7713-7726 (2015)
  6. Masterson JC, McNamee EN, Fillon SA, Hosford L, Harris R, Fernando SD, Jedlicka P, Iwamoto R, Jacobsen E, Protheroe C, Eltzschig HK, Colgan SP, Arita M, Lee JJ, *Furuta GT. Eosinophil-mediated signaling attenuates inflammatory responses in experimental colitis. Gut 64, 1236-1247 (2015)
  7. Nishiokada A, Miyoshi M, Fujiwara M, Aoyama-Ishikawa M, Maeshige M, Takahashi M, Hamada Y, Usami Y, Honda M, Arita M, *Usami M. Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 week in endotoxemic rats using LC-ESI-MS/MS. Clin Nutr 34, 685-693 (2015)
  8. *Kunisawa J, *Arita M, Hayasaka T, Harada T, Iwamoto R, Nagasawa R, Shikata S, Nagatake T, Suzuki H, Hashimoto E, Kurashima Y, Suzuki Y, Arai H, Setou M, Kiyono H. Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut. Sci Rep 5, 9750 (2015)
  9. Miyamoto J, Mizukure T, Park S, Kishino S, Kimura I, Hirano K, Bergamo P, Rossi M, Suzuki T, Arita M, Ogawa J, *Tanabe S. A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40/MEK-ERK pathway. J Biol Chem 290, 2902-2918 (2015)
  10. *Hashimoto M, Katakura M, Tanabe Y, Al Mamun A, Inoue T, Hossain S, Arita M, Shido O. n-3 fatty acids effectively improve the reference memory-related learning ability associated with increased brain docosahexaenoic acid-derived docosanoids in aged rats. Biochim Biophys Acta 1851, 203-209 (2015)
  11. *Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int 64, 27-34 (2015)
  12. *Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, Kanazawa M, VanderGheynst J, Fiehn O, Arita M. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods Jun;12(6):523-6(2015)

>> List

2014

  1. Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, *Arita M. 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 211, 1673-1687 (2014)
  2. Tani Y, Isobe Y, Imoto Y, Segi-Nishida E, Sugimoto Y, Arai H, *Arita M. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J 28, 4036-4043 (2014)
  3. Yokokura Y, Isobe Y, Matsueda S, Iwamoto R, Goto T, Yoshioka T, Urabe D, Inoue M, Arai H, *Arita M. Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite. J Biochem 156, 315-321 (2014)
  4. Kubota T, *Arita M, Isobe Y, Iwamoto R, Goto T, Yoshioka T, Urabe D, Inoue M, Arai H. Eicosapentaenoic acid is converted via omega-3 epoxygenation to anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid. FASEB J 28, 586-593 (2014)
  5. Demetz E, Schroll A, Auer K, Heim C, Patsch JR, Eller P, Theurl M, Lener D, Stanzl U, Seifert M, Haschka D, Asshoff M, Dichtl S, Nairz M, Huber E, Stadlinger M, Li X, Pallweber P, Scharnagl H, Stojakovic T, Marz W, Kleber ME, Garlaschelli K, Uboldi P, Catapano AL, Stellaard F, Rudling M, Kuba K, Imai Y, Arita M, Pramstaller PP, Tietge UJF, Trauner M, Norata GD, Claudel T, Hicks AA, Weiss G, *Tancevski I. The arachidonic acid metabolome as conserved regulator of cholesterol metabolism. Cell Metab 20, 787-798 (2014)
  6. *Hirahashi J, Kawahata K, Arita M, Iwamoto R, Hishikawa K, Honda M, Hamasaki Y, Tanaka M, Okubo K, Kurosawa M, Takase O, Nakakuki M, Saiga K, Suzuki K, Kawachi S, Tojo A, Seki G, Marumo T, Hayashi M, Fujita T. Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis. Sci Rep 4, 6406 (2014)
  7. Iwaki S, Hokamura K, Ogawa M, Takehara Y, Muramatsu Y, Yamane T, Hirabayashi K, Morimoto Y, Hagisawa K, Nakahara K, Mineno T, Terai T, Komatsu T, Ueno T, Tamura K, Adachi Y, Hirata Y, Arita M, Arai H, Umemura K, Nagano T, *Hanaoka K. A design strategy for small molecule-based targeted MRI contrast agents: their application for detection of atherosclerotic plaques. Org Biomol Chem 12, 8611-8618 (2014)
  8. Masterson JC, McNamee EN, Fillon SA, Hosford L, Harris R, Fernando SD, Jedlicka P, Iwamoto R, Jacobsen E, Protheroe C, Eltzschig HK, Colgan SP, Arita M, Lee JJ, *Furuta GT. Eosinophil-mediated signaling attenuates inflammatory responses in experimental colitis. Gut in press
  9. Nishiokada A, Miyoshi M, Fujiwara M, Aoyama-Ishikawa M, Maeshige M, Takahashi M, Hamada Y, Usami Y, Honda M, Arita M, *Usami M. Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 week in endotoxemic rats using LC-ESI-MS/MS. Clin Nutr in press
  10. Onuma H, *Komatsu T, Arita M, Hanaoka K, Ueno T, Terai T, Nagano T, *Inoue T. Rapidly rendering cells phagocytic through a cell-surface display technique and concurrent Rac activation. Sci Signal 7, rs4 (2014)
  11. *Kunisawa J, Hashimoto E, Inoue A, Nagasawa R, Suzuki Y, Ishikawa I, Shikata S, Arita M, Aoki J, Kiyono H. Regulation of intestinal IgA responses by dietary palmitic acid and its metabolism. J Immunol 193, 1666-1671 (2014)
  12. Nakashima C, *Otsuka A, Kitoh A, Honda T, Egawa G, Nakajima S, Nakamizo S, Arita M, Kubo M, Miyachi Y, *Kabashima K. Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis. J Allergy Clin Immunol 134, 100-107 (2014)
  13. Taguchi A, *Kawana K, Tomio K, Yamashita A, Isobe Y, Nagasaka K, Koga K, Inoue T, Nishida H, kojima S, Adachi K, Matsumoto Y, Arimoto T, Wada-Hiraike O, Oda K, kang JX, Arai H, *Arita M, Osuga Y, Fujii T. Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyusaturated fatty acids in vitro and in vivo. PLoS One 27, e89605 (2014)
  14. Katakura M, *Hashimoto M, Inoue T, Al Mamun A, Tanabe Y, Iwamoto R, Arita M, Tsuchikura S, Shido O. Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR.Cg-Leprcp/NDmcr rats, a metabolic syndrome model. Molecules 19, 3247-3263 (2014)
  15. Ueda T, *Fukunaga K, Seki H, Miyata J, Arita M, Miyasho T, Obata T, Asano K, Betsuyaku T, Takeda J. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis. Crit Care Med 42, e288-295 (2014)
  16. Isobe Y, *Arita M. Identification of novel omega-3 fatty acid-derived bioactive metabolites based on a targeted lipidomics approach. J Clin Biochem Nutr 55, 79-94 (2014)

>> List

2013

  1. Isobe Y, *Arita M, Iwamoto R, Urabe D, Todoroki H, Masuda K, Inoue M, Arai H. Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3. J Biochem 153, 355-360 (2013)
  2. Miyata J, Fukunaga K, Iwamoto R, Isobe Y, Niimi K, Takamiya R, Takihara T, Tomomatsu K, Suzuki Y, Oguma T, Sayama K, Arai H, Betsuyaku T, Arita M, *Asano K. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin Immunol 131, 353-360 (2013)
  3. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanabe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, *Imai Y. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153, 112-125 (2013)
  4. Taketomi Y, Ueno N, Kojima T, Sato H, Murase R, Yamamoto K, Tanaka S, Sakanaka M, Nakamura M, Nishito Y, Kawana M, Kambe N, Ikeda K, Taguchi R, Nakamizo S, Kabashima K, Gelb MH, Arita M, Yokomizo T, Nakamura M, Watanabe K, Hirai H, Nakamura M, Okayama Y, Ra C, Aritake K, Urade Y, Morimoto K, Sugimoto Y, Shimizu T, Narumiya S, Hara S, *Murakami M. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol 14, 554-563 (2013)
  5. Miki Y, Yamamoto K, Taketomi Y, Sato H, Shimo K, Kobayashi T, Ishikawa Y, Ishii T, Nakanishi H, Ikeda K, Taguchi R, Kabashima K, Arita M, Arai H, Lambeau G, Bollinger JM, Hara S, Gelb MH, *Murakami M. Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J Exp Med 210, 1217-1234 (2013)
  6. Kishino S, Takeuchi M, Park S, Hirata A, Kitamura N, Kunisawa J, Kiyono H, Iwamoto R, Isobe Y, Arita M, Arai H, Ueda K, Shima J, Takahashi S, Yokozeki K, Shimizu S, *Ogawa J. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc Natl Acad Sci USA 110, 17808-17813 (2013)
  7. Yamashita A, *Kawana K, Tomio K, Taguchi A, Isobe Y, Iwamoto R, Masuda K, Furuya H, Nagamatsu T, Nagasaka K, Oda K, Wada-Hiraike O, Yamashita T, Taketani Y, Kang JX, Arai H, *Arita M, Kozuma S, Fujii T. Increased tissue level of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. Sci Rep 3, 3113 (2013)
  8. Tomio K, *Kawana K, Taguchi A, Isobe Y, Iwamoto R, Yamashita A, Kojima S, Mori M, Nagamatsu T, Arimoto T, Oda K, Osuga Y, Taketani Y, Kang JX, Arai H, *Arita M, Kozuma S, Fujii T. Omega-3 polyunsaturated fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models. PLoS One 8, e73085 (2013)
  9. Fujieda Y, Manno A, Hayashi Y, Rhodes N, Guo L, Arita M, Bamba T, *Fukusaki E. Inflammation and resolution are associated with upregulation of fatty acid beta-oxidation in zymosan-induced peritonitis. PLoS One 8, e66270 (2013)
  10. *Maekawa K, Hirayama A, Iwata Y, Tajima Y, Nishimaki-Mogami T, Sugawara S, Ueno N, Abe H, Ishikawa M, Murayama M, Matsuzawa Y, Nakanishi H, Ikeda K, Arita M, Taguchi R, Minamino N, Wakabayashi S, Soga T, Saito Y. Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy. J Mol Cell Cardiol 59, 76-85 (2013)
  11. Tajima Y, Ishikawa M, Maekawa K, Murayama M, Senoo Y, Nishimaki-Mogami T, Nakanishi H, Ikeda K, Arita M, Taguchi R, Okuno A, Mikawa R, Niida S, Takikawa O, *Saito Y. Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease. Lipids Health Dis 12, 68 (2013)
  12. Juman S, *Hashimoto M, Katakura M, Inoue T, Tanabe Y, Arita M, Miki T, Shido O. Effects of long-term oral administration of arachidonic acid and docosahexaenoic acid on the immune functions of young rats. Nutrients 5, 1949-1961 (2013)

>> List

2012

  1. Isobe Y, *Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, Taguchi R, Masuda K, Sasaki K, Urabe D, Inoue M, Arai H. Identification and structure determination of novel anti-inflammatory mediator resolvin E3: 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem 287, 10525-10534 (2012)
  2. Lee HC, Inoue T, Sasaki J, Kubo T, Matsuda S, Nakasaki Y, Hattori M, Tanaka F, Udagawa O, Kono N, Itoh T, Ogiso H, Taguchi R, Arita M, Sasaki T, *Arai H. LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice. Mol Biol Cell 23, 4689-4700 (2012)
  3. *Takamiya R, Fukunaga K, Arita M, Miyata J, Seki H, Minematsu N, Suematsu M, Asano K. Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress. FEBS Open Bio 2, 328-333 (2012)
  4. *Arita M. Mediator lipidomics in acute inflammation and resolution. J Biochem (Invited review) 152, 313-319 (2012)
  5. Isobe Y, Kato T, *Arita M. Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front Immunol 3, 270 (2012)
  6. *Arita M, Iwamoto R, Isobe Y. Mediator lipidomics in inflammation research. Lipidomics, Technologies and Applications. (Ekroos, K. ed.), pp.219-230, Willey-VCH, Weinheim.(2012)

>> List

2011

  1. Yamada T, Tani Y, Nakanishi H, Taguchi R, *Arita M, Arai H. Eosinophils promote resolution of acute peritonitis by producing pro-resolving mediators in mice. FASEB J 25 561-568 (2011)
  2. Sasaki K, Urabe D, Arai H, Arita M, *Inoue M. Total synthesis and bioactivities of two proposed structures of maresin. Chem Asian J 6, 534-543 (2011)

>> List

2010

  1. White PJ, Arita M, Taguchi R, Kang JX, *Marette A. Transgenic restoration of long chain omega-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high fat-fed mice. Diabetes 59, 3066-3073 (2010)
  2. Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, *Levy BD. The anti-inflammatory and pro-resolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol 184, 836-843 (2010)
  3. Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, *Serhan CN. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 285, 3451-3461 (2010)
  4. Marcheselli VL, Mukherjee PK, Arita M, Hong S, Antony R, Sheets K, Winkler JW, Petasis NA, Serhan CN, *Bazan NG. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot Essent Fatty Acids 82, 27-34 (2010)
  5. Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kusumi H, Arita M, Azuma T, *Yoshida M. Lipoxin A4 reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of NF-kB activation. J Pharmacol Exp Ther 332, 541-548 (2010)
  6. Ishida T, *Yoshida M, Arita M, Nishitani Y, Nishiumi S, Masuda A, Mizuno S, Takagawa T, Morita Y, Kusumi H, Inokuchi H, Serhan CN, Blumberg RS, Azuma T. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 16, 87-95 (2010)
  7. Oushiki D, Kojima H, Terai T, Arita M, Hanaoka K, Urano Y, *Nagano T. Development and application of a near-infrared fluorescent probe for oxidative stress based on differential reactivity of linked cyanine dyes. J Am Chem Soc 132, 2795-2801 (2010)
  8. Seki H, Sasaki T, Ueda T, *Arita M. Resolvins as regulators of the immune system. Scientific World Journal 10, 818-831 (2010)

>> List

2009

  1. Ogawa S, Urabe D, Yokokura Y, Arai H, Arita M, *Inoue M. Total synthesis and bioactivity of resolvin E2. Org Lett 11, 3602-3605 (2009)
  2. Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, *Dana R. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Opthalmol Vis Sci 50, 4743-4752 (2009)
  3. Seki H, Tani Y, *Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat 89, 126-130 (2009)

>> List

2008

  1. Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, *Serhan CN. Resolvin E1, and EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848-855 (2008)

>> List

2007

  1. Schwab JM, Chiang N, Arita M, *Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007)
  2. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, *Serhan CN. Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation. J Immunol 178, 3912-3917 (2007)
  3. Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, *Colgan SP. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 21, 3162-3170 (2007)
  4. *Bannenberg G, Arita M, Serhan CN. Endogenous receptor agonists: resolving inflammation. Scientific World Journal 7, 1440-1462 (2007)

>> List

2006

  1. Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun YP, Uddin J, Petasis NA, *Serhan CN. Metabolic inactivation of resolvin E1 and stabilization of its anti- inflammatory actions. J Biol Chem 281, 22847-22854 (2006)
  2. #Wada K, #Arita M, Nakajima A, Katayama K, Kudo C, Kamisaki Y, *Serhan CN. Leukotriene B4 and lipoxin A4 are counterregulatory signals for neural stem cell proliferation and differentiation. FASEB J 20, 1785-1792 (2006)  (# equal first authors)
  3. Fukunaga K, Arita M, Takahashi M, Morris AJ, Pfeffer M, *Levy BD. Identification and functional characterization of a presqualene diphosphate phosphatase. J Biol Chem 281, 9490-9497 (2006)
  4. Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio K, Hong S, Arita M, *Serhan CN. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol 13, 1193-1202 (2006)
  5. Hasturk H, Kantarci IA, Ohira T, Arita M, Ebrahimi N, Petasis N, Levy BD, Serhan CN, *Van Dyke TE. RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. FASEB J 20, 401-403 (2006)
  6. Shibata N, Jishage K, Arita M, Watanabe M, Kawase Y, Nishikawa K, Natori Y, Inoue H, Shimano H, Yamada N, Tsujimoto M, *Arai H. Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis. FASEB J 20, 2642-2644 (2006)

>> List

2005

  1. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, *Serhan CN. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201, 713-722 (2005)
  2. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman J, Petasis NA, Blumberg RS, *Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 102, 7671-7676 (2005)
  3. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger K, Hong S, *Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174, 4345-4355 (2005)
  4. Chiang N, Arita M, *Serhan CN. Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins andtheir receptor ALX. Prostaglandins Leukot Essent Fatty Acids 73: 163-77 (2005)

>> List

2004

  1. Ohira T, Bannenberg G, Arita M, Takahashi M, Ge Q, Van Dyke TE, Stahl GL, Serhan CN, *Badway JA. A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils. J Immunol 173, 2091-2098 (2004)
  2. *Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins and protectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39: 1125-1132 (2004)
  3. *Serhan CN, Gotlinger K, Hong S, and Arita M. Resolvins, Docosatrienes, and Neuroprotectins, novel omega-3 derived mediators, and their aspirin-triggered endogenous epimers: An overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 73:155-72 (2004)

>> List

2003

  1. Devchand PR, Arita M, Hong S, Bannenberg GL, Moussignac RL, Gronert K, *Serhan CN. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J 17, 652-659 (2003)
  2. Ariel A, Chiang N, Arita M, Petasis NA, *Serhan CN. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 170, 6266-6272 (2003)
  3. Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, *Serhan CN. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 170, 2688-2694 (2003)
  4. Horiguchi M, Arita M, Kaempf-Rotzoll DE, Tsujimoto M, Inoue K, *Arai H. PH-dependent translocation of alpha-tocopherol transfer protein (alpha-TTP) between hepatic cytosol and late endosomes. Genes Cells 8:789-800 (2003)

>> List

1995-2002

  1. *Yokota T, Igarashi K, Uchihara T, Jishage K, Tomita H, Inaba A, Li Y, Arita M, Suzuki H, Mizusawa H, Arai H. Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: Model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci USA 98:15185-90 (2001)
  2. Shibata N, Arita M, Misaki Y, Dohmae N, Takio K, Ono T, Inoue K, *Arai H. Supernatant　protein　factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer　protein and enhances cholesterol biosynthesis. Proc Natl Acad Sci USA 98:2244- 49 (2001)
  3. Jishage K, Arita M, Igarashi K, Iwata T, Watanabe M, Ogawa M, Ueda O, Kamada N, Inoue K, Arai H, *Suzuki H. Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J Biol Chem 276:1669-72 (2001)
  4. *Yokota T, Uchihara T, Kumagai I, Shiojiri T, Pang J, Arita M, Arai H, Hayashi M, Kiyosawa M, Okeda R, Mizusawa H. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 68:521-25 (2000)
  5. Murakami M, Kambe T, Shimbara S, Higashino K, Hanasaki K, Arita H, Horiguchi M, Arita M, Arai H, Inoue K, *Kudo I. Different functional aspects of the group II subfamily (Type IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostagrandin generation. Implications of phospholipid scramblase-mediated cellular membrane perturbation. J Biol Chem 274:31435-44 (1999)
  6. Hosomi A, Goto K, Kondo H, Iwatsubo T, Yokota T, Ogawa M, Arita M, Aoki J, *Arai H, Inoue K. Localization of alpha-tocopherol transfer protein in rat brain. Neurosci Lett 256:159-62 (1998)
  7. Arita M, Sato Y, *Arai H, Inoue K. Binding of alpha-tocopherylquinone, an oxidized form of alpha-tocopherol, to glutathione-S-transferase in the liver cytosol. FEBS Lett 436:424-26 (1998)
  8. Kim H, Arai H, Arita M, Sato Y, Ogihara T, Inoue K, Mino M, *Tamai H. Effect of alpha-tocopherol status on alpha-tocopherol transfer protein expression and its messenger RNA level in rat liver. Free Rad Res 28:87-92 (1998)
  9. Arita M, Nomura K, *Arai H, Inoue K. Alpha-tocopherol transfer protein stimulates the secretion of alpha-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway.    Proc Natl Acad Sci USA 94:12437-41 (1997)
  10. Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, *Arai H, Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105-8 (1997)
  11. *Yokota T, Shiojiri T, Gotoda T, Arita M, Arai H, Ohga T, Kanda T, Suzuki J, Imai T, Matsumoto H, Harino S, Kiyosawa M, Mizusawa H, Inoue K. Friedreich-like ataxia with retinis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol 41:826-37 (1997)
  12. Kim H, Arai H, Arita M, Sato Y, Ogihara T, Tamai H, Inoue K, *Mino M. Age-related changes of alpha-tocopherol transfer protein expression in rat liver. J Nutr Sci Vitaminol 42:11-18 (1996)
  13. Gotoda T, Arita M, Arai H, Inoue K, Yokota T, Fukuo Y, Yazaki Y, *Yamada N. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer-protein. N Engl J Med 333:1313-18 (1995)
  14. Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, *Koenig M. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 9:141-45 (1995)
  15. Arita M, Sato Y, Miyata A, Tanabe T, Takahashi E, Kayden HJ, Arai H, *Inoue K. Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem J 306:437-43 (1995)

>> List

和文誌

List

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
1995-2006
欧文誌

 

2023

  1. 有田誠：ω３脂肪酸の代謝動態と疾患制御：実験医学増刊「脂質疾患学」（羊土社）41(17), 2726-2732 (2023)
  2. 津川裕司、有田誠：脂質疾患研究を加速させるノンターゲットリピドミクス：実験医学増刊「脂質疾患学」（羊土社）41(17), 2764-2771 (2023)
  3. 内野春希、有田誠：脂質クオリティの多様性を解き明かす最先端リピドミクス解析技術：実験医学増刊「マルチオミクス」（羊土社）41, 2408-2415 (2023)
  4. 両角諭、岡橋伸幸、有田誠：腸内細菌が産生する脂質代謝物の構造と機能：生化学（日本生化学会）Vol.95(4), 428-435 (2023)
  5. 有田誠：リピドームアトラス：ファルマシア（日本薬学会）Vol.59(1), 9-13 (2023)

>> List

2022

  1. 林和也、磯部洋輔、有田誠：ω３脂肪酸の代謝と抗炎症作用：臨床免疫・アレルギー科（科学評論社）Vol.78(6), 690-696 (2022)
  2. 津川裕司、有田誠：リピドミクス：実験医学別冊 論文図表を読む作法（羊土社）pp.144-146 (2022)
  3.  岡橋伸幸、有田誠：腸内細菌が生成する脂質代謝物の構造と機能：肥満研究（日本肥満学会）Vol.28(1), 10-15 (2022)
  4. 有田誠：最先端リピドミクスで解き明かす生命の脂質多様性と疾患制御：生化学（日本生化学会）Vol.94 No.1, pp.1-9 (2022)

>> List

2021

  1. 上田政宏、岡橋伸幸、有田誠：質量分析を用いた細菌のリピドミクス：JSBMS Letters（日本医用マススペクトル学会）Vol.46 No.3, 38-42 (2021)
  2. 岡橋伸幸、松田史生、有田誠：質量分析法を使った未知代謝物の計測と同定：生物工学会誌Vol.99 No.5, 233-236 (2021)
  3. 有田誠：生命の脂質多様性から解き明かす病態・バイオロジー研究：実験医学別冊 メタボロミクス実践ガイド（羊土社）pp.283-285 (2021)

>> List

2020

  1. 岡橋伸幸、上田政宏、有田誠：マイクロバイオームのリピドミクス：ヒトマイクロバイオーム研究最前線Vol.2 (NTS)pp.71-78(2020)
  2. 藤原昂平、礒部洋輔、有田誠：ω３脂肪酸から生じる脂質メディエーターの生理機能と代謝経路：BIO INDUSTRY（シーエムシー出版）Vol.37 No.10 （2020）

>> List

2019

  1. 飯野雄大、永沼達郎、有田誠：皮膚疾患とリピドミクス：医学のあゆみ（医歯薬出版）270, 409-415 (2019)
  2. 有田誠：生体制御にかかわる多彩なリポクオリティ〜基礎から病態まで〜（企画・編集）：The Lipid（メディカルレビュー社）Vol.30 No.4 (2019)
  3. 有田誠：脂肪酸クオリティによる炎症の制御：The Lipid（メディカルレビュー社）Vol.30, 355-361 (2019)
  4. 安田柊、岡橋伸幸、上田政宏、有田誠：腸内細菌のリポクオリティと生体制御：The Lipid（メディカルレビュー社）Vol.30, 393-399 (2019)
  5. 有田誠：脂質クオリティ研究の基礎と臨床（企画・編集）：医学のあゆみ（医歯薬出版）269巻13号 (2019)
  6. 有田誠：ω３脂肪酸クオリティによる疾患制御：医学のあゆみ（医歯薬出版）269, 967-970 (2019)
  7. 宮田純、福永興壱、有田誠：アレルギー疾患における好酸球の脂肪酸代謝異常：医学のあゆみ（医歯薬出版）269, 1008-1014 (2019)
  8. 内野春希、津川裕司、有田誠：リポクオリティの違いを捉えるノンターゲット脂質解析：医学のあゆみ（医歯薬出版）269, 1238-1244 (2019)
  9. 宮田純、川島祐介、小原収、別役智子、福永興壱、有田誠：ヒト好酸球のマルチオミクス解析で紐解く、好酸球性副鼻腔炎・重症喘息の分子機序：アレルギー（日本アレルギー学会）　68, 86-91 (2019)
  10. 宮田純、有田誠：アレルギー性好酸球における脂質代謝異常のメタボローム解析：臨床免疫・アレルギー科（科学評論社）71, 34-40 (2019)
  11. 有田誠：第１部 生体における脂質の構造と機能 4.脂肪酸：実験医学別冊 脂質解析ハンドブック（羊土社）pp.49-54 (2019)

>> List

2018

  1. 有田誠：第3章2.ω３脂肪酸の代謝と抗炎症作用：食品機能性脂質の基礎と応用（シーエムシー出版）pp.134-139 (2018)
  2. 青木秀憲、有田誠：脂肪酸代謝バランスによるマクロファージの機能制御：実験医学（羊土社）36, 2353-2357 (2018)
  3. 有田誠：脂質クオリティ 〜生命機能と健康を支える脂質の多様性〜（企画・編集）：実験医学増刊（羊土社）Vol.36 No.10 (2018)
  4. 有田誠：概論/リポクオリティから解き明かす生命現象：実験医学増刊「脂質クオリティ」（羊土社）36, 1580-1584 (2018)
  5. 有田誠：脂肪酸クオリティの生理的意義と疾患制御：実験医学増刊「脂質クオリティ」（羊土社）36, 1585-1590 (2018)
  6. 池田和貴、青柳良平、有田誠：リポクオリティを識別するリピドミクス解析技術：実験医学増刊「脂質クオリティ」（羊土社）36, 1797-1803 (2018)
  7. 津川裕司、池田和貴、有田誠、有田正規：脂質クオリティを捉える解析手法とデータベース：実験医学増刊「脂質クオリティ」（羊土社）36, 1804-1811 (2018)
  8. 有田誠：脂肪酸クオリティの多様性と病態（企画・編集）：医学のあゆみ３/17号 （医歯薬出版）Vol.264 No.11(2018)
  9. 吉田美桜、礒部洋輔、石原知明、有田誠：ω３脂肪酸由来脂質メディエーターと炎症制御（特集：脂質メディエーターと病態）：細胞（ニューサイエンス社） 50(3), 8-12（2018）

>> List

2017

  1. 有田誠：ω３脂肪酸の代謝と抗炎症作用に関する研究：脂質栄養学（日本脂質栄養学会）26, 27-34 (2017)
  2. 有田誠：リポクオリティと炎症・免疫の制御(2017)（企画・編集）：炎症と免疫７月号
  3. 永沼達郎、有田誠：脂肪酸クオリティと炎症・アレルギーの制御：炎症と免疫（先端医学社）25, 265-270 (2017)
  4. 石原知明、磯部洋輔、有田誠：ω３脂肪酸の代謝と抗炎症作用（特集 ここまで明らかになったω３脂肪酸）：ビタミン 91, 537-541 (2017)
  5. 有田誠：脂肪酸代謝バランスによる炎症性疾患の制御：FOOD STYLE 21（食品化学新聞社）21, 45-48 (2017)

>> List

2016

  1. 有田誠：ω３脂肪酸はなぜ体に良いのか その分子メカニズムに迫る：Therapeutic Research 37, 101-103 (2016)
  2. 有田誠：機能性脂質・脂肪酸の多彩な生理活性と病態形成（企画・編集）：血管医学７月号 （2016）
  3. 有田誠：Overview/リポクオリティが制御する血管医学：血管医学（メディカルレビュー社）17, 115-117 (2016)
  4. 遠藤仁、有田誠：脂肪酸クオリティ制御と血管医学：血管医学（メディカルレビュー社）17, 137-143 (2016)
  5. 有田誠：リピドミクスによる脂肪酸代謝と疾患制御の解析：生体の科学「脂質ワールド」（医学書院） 67, 189-192 (2016)
  6. 有田誠：ビジュアルレビュー：脂肪酸クオリティによる炎症性疾患の制御：感染炎症免疫46, 22-30 (2016)

>> List

2015

  1. 有田誠：総説：ω３脂肪酸の分子栄養学：アンチエイジング医学（メディカルレビュー社）11, 845-851 (2015)
  2. 有田誠：ω３脂肪酸のメタボローム解析と心臓リモデリング抑制作用：内分泌・糖尿病・代謝内科「代謝疾患とメタボローム」（科学評論社）41, 380-384 (2015)
  3. 有田誠：多価不飽和脂肪酸の代謝と炎症の制御：医学のあゆみ「プロスタグランジンと炎症」（医歯薬出版）254; 1127-1130 (2015)
  4. 有田誠：ω３脂肪酸の代謝と疾患制御のメタボロミクス：実験医学増刊号「脂質疾患学」（羊土社）33; 2361-2366 (2015)
  5. 有田誠：炎症の収束に関わる脂肪酸代謝系とその機能：別冊BIO Clinica「慢性炎症と疾患」（北隆館）4(2); 27-31 (2015)
  6. 有田誠：脂肪酸代謝と炎症のメタボロミクス：臨床免疫・アレルギー科（科学評論社）63; 118-124 (2015)
  7. 有田誠：ω３脂肪酸の代謝と心臓保護作用：別冊BIO Clinica（北隆館）4; 99-110 (2015)
  8. 有田誠、遠藤仁：ω３系多価不飽和脂肪酸による心臓リモデリング抑制：循環plus（メディカルトリビューン社）15; 7-9 (2015)
  9. 有田誠：レゾルビンとプロテクチン：サイトカイン・増殖因子キーワード事典（羊土社）344-346（2015）
  10. 加藤大雅、有田誠：第５章 第９節：炎症収束性脂質メディエーター：脂質代謝異常と関連疾患（下巻）（Life-Science Information Center）249-254（2015）

>> List

2014

  1. 有田誠：脂肪酸代謝バランスと炎症の制御：実験医学増刊号「炎症」（羊土社）32; 2796-2802 (2014)
  2. 今井由美子、有田誠：呼吸器の脂肪酸代謝系がインフルエンザウイルス感染症から体を守る：実験医学増刊号「驚愕の代謝システム」（羊土社）32; 2389-2396 (2014)
  3. 有田誠：脂肪酸代謝と炎症のメタボロミクス：医学のあゆみ（医歯薬出版）249; 318-322 (2014)
  4. 磯部洋輔、有田誠：ω３脂肪酸の抗炎症作用とメタボロミクス：医学のあゆみ（医歯薬出版）248; 984-988 (2014)
  5. 有田誠：炎症を制御する脂肪酸代謝物の包括的メタボロミクス：医学のあゆみ（医歯薬出版）248; 1199-1204 (2014)
  6. 有田誠：炎症の収束に関わる脂質メディエーター：炎症と免疫（先端医学社）22; 79-84 (2014)
  7. 小林哲幸、有田誠：第１章：脂質の構造と代謝：生体膜の分子機構（梅田真郷/編）化学同人1-39 (2014)

>> List

2013

  1. 有田誠、池田和貴：脂質メタボロミクス：医用質量分析ガイドブック（診断と治療社）p180-185 (2013)
  2. 久保田唯史、磯部洋輔、有田誠：ω３脂肪酸代謝産物のメタボローム解析と抗炎症作用：血栓と循環（メディカルレビュー社）21; 195-199 (2013)
  3. 有田誠：オメガ３系多価不飽和脂肪酸の代謝と抗炎症作用：Cardiovascular Contemporary (Medicine Rattle) 2; 32-37 (2013)
  4. 宮田純、有田誠：リピドミクス解析のアレルギー研究への応用：実験医学増刊「病態の理解に向かうアレルギー疾患研究」（羊土社）31; 2852-2858 (2013)
  5. 有田誠：炎症のメタボローム解析から明らかになった好酸球の新規機能：生化学（日本生化学会） 85; 97-102 (2013)
  6. 有田誠：オメガ３脂肪酸の代謝と炎症の制御：BIOINDUSTRY（シーエムシー出版） 347; 11-17 (2013)
  7. 松枝進之介、磯部洋輔、有田誠：好酸球による炎症とホメオスタシスの制御：炎症と免疫（先端医学社） 21,450-454 (2013)
  8. 有田誠：脂肪酸バランスと炎症の制御：静脈経腸栄養（JSPEN） 28, 929-932 (2013)
  9. 松枝進之介、有田誠：組織炎症の制御におけるn-3/n-6系脂肪酸バランスの重要性：内分泌・糖尿病・代謝内科（科学評論社）36; 485-489 (2013)
  10. 磯部洋輔、岩本涼、有田誠：n-3系脂肪酸の代謝と抗炎症作用についてのメタボローム解析：遺伝子医学MOOK24「最新生理活性脂質研究」（メディカルドウ）p286-290 (2013)
  11. 遠藤仁、有田誠：そうだったんだ脂肪酸（循環器疾患との深い関係）（文光堂） p84-90 (2013)
  12. 有田誠：炎症の収束に関わる脂質メディエーターの新規機能：バイオサイエンスとインダストリー（バイオインダストリー協会） 71； 14-7 (2013)

>> List

2012

  1. 有田誠：炎症・代謝性疾患に潜む脂質メタボリズム（企画、編集）：実験医学（羊土社）2012年2月号
  2. 有田誠：概論/脂肪酸の質の違いについて考える：実験医学（羊土社） 30, 406-411 (2012)
  3. 磯部洋輔、有田誠：多価不飽和脂肪酸の代謝と炎症の制御：実験医学（羊土社） 30, 423-428 (2012)
  4. 有田誠、齋藤嘉郎、田口良、西島正弘：メタボローム新技術が切り拓くこれからの脂質バイオロジー研究：実験医学（羊土社） 30, 446-454 (2012)
  5. 有田誠：ω３系多価不飽和脂肪酸由来の生理活性脂質と抗炎症作用：臨床検査（医学書院）56; 165-70(2012)
  6. 有田誠：ω３/ω６脂肪酸バランスと炎症の制御：Surgery Frontier（メディカルレビュー社） 19; 428-30 (2012)

>> List

2011

  1. 有田誠：炎症の収束における脂質メディエーター代謝系のダイナミックな変化とその機能的役割：実験医学増刊「慢性炎症：多様な疾患の基盤病態」（羊土社）29; 1524-8 (2011)
  2. 有田誠：メタボローム解析から明らかになった炎症の収束にかかわる好酸球と脂質メディエーターの新規機能：内分泌・糖尿病・代謝内科（科学評論社）33; 573-7 (2011)
  3. 有田誠：ω３系脂肪酸の代謝と抗炎症作用：アンチエイジング医学（メディカルレビュー社） 7, 22-26 (2011)
  4. 遠藤仁、有田誠：脂質メディエーター (特集 炎症と動脈硬化--基礎・臨床研究の最新動向)： 日本臨床（日本臨床社） 69, 34-38 (2011)

>> List

2010

  1. 有田誠：炎症反応を制御する抗炎症性脂質メディエーター：実験医学増刊「分子から個体へと深化する脂質生物学」（羊土社） 28, 3402-3408 (2010)
  2. 有田誠：脂肪酸代謝と炎症のメタボロミクス：メタボロミクス：その解析技術と臨床・創薬応用研究の最前線, 遺伝子医学MOOK（メディカルドウ） 16, 179-184 (2010)
  3. 遠藤仁、有田誠：血小板内皮細胞相互作用と脂質メディエーター：血栓と循環（メディカルレビュー社） 18, 135-139 (2010)

>> List

2009

  1. 谷友香子、有田誠：血小板—内皮細胞相互作用と抗炎症性脂質メディエーター：血管医学（メディカルレビュー社） 10, 143-149 (2009)
  2. 有田誠：多価不飽和脂肪酸と疾患（炎症性腸疾患）：治療学（ライフサイエンス出版） 43, 56-60 (2009)
  3. 有田誠：n-3系多価不飽和脂肪酸の抗炎症作用のメタボロミクス：食品と開発（UBMメディア） 45, 21-23 (2009)
  4. 佐々木崇晴、磯部洋輔、有田誠：n-3系脂肪酸の抗炎症作用についての新しい分子生物学的展開：外科と代謝・栄養（日本外科代謝栄養学会） 43, 155-160 (2009)

>> List

2008

  1. 有田誠：ω３系脂肪酸由来の抗炎症性代謝物の構造と機能：生化学（日本生化学会） 80, 1042-1046 (2008)
  2. 有田誠：脂質性メディエーターと炎症反応の収束：感染炎症免疫（医薬の門社） 38, 14-23 (2008)
  3. 有田誠：ω３多価不飽和脂肪酸に由来する活性代謝物：The Lipid（メディカルレビュー社） 19, 384-389 (2008)
  4. 有田誠、磯部洋輔：ω３脂肪酸系メディエーターと炎症反応の収束：化学と生物（日本農芸化学会） 46, 316-322 (2008)
  5. 磯部洋輔、中西広樹、田口良、有田誠：ω３多価不飽和脂肪酸と炎症のメタボロミクス：臨床化学（日本臨床化学会） 37, 347-353 (2008)
  6. 有田誠：ω３脂肪酸由来の抗炎症性メディエーター：脂質栄養学（日本脂質栄養学会） 17, 33-40 (2008)
  7. 有田誠：ω３高度不飽和脂肪酸の抗炎症作用、Adiposcience（フジメディカル出版） 5, 37-42 (2008)
  8. 有田誠：オメガ3脂肪酸系メディエーター：BIO Clinica（北隆館）23 (1), 56 (2008)

>> List

2007

  1. 有田誠：高度不飽和脂肪酸由来の抗炎症性メディエーター：細胞工学（秀潤社） 26,1241-1245 (2007)
  2. 有田誠：オメガ3脂肪酸から産生される抗炎症性脂質メディエーター：ファルマシア（日本薬学会） 43, (2007)
  3. 有田誠、Charles N. Serhan：炎症を緩和するケミカルメディエーター　オメガ3脂肪酸に由来するレゾルビンとプロテクチン：蛋白質核酸酵素（共立出版） 52,348-354 (2007)

>> List

1995-2002

  1. 有田誠、新井洋由、井上圭三：α-トコフェロール輸送蛋白質：蛋白質核酸酵素増刊「脂質の分子生物学と病態生化学」（共立出版）Vol.44, 1219-1226 (1999)
  2. 有田誠、新井洋由、井上圭三：ビタミン研究のブレークスル−・家族性ビタミンＥ欠乏症とビタミンＥ輸送タンパク質：ビタミン（日本ビタミン学会） 72, 557-560 (1998)

>> List